Included support
- +Hospital matching
- +Record review
- +Care coordination
- +Travel support
- +Interpretation support

Lesion-conformal/intensity-modulated radiotherapy (ISRT/IMRT) may be considered in non-Hodgkin lymphoma with local residual/relapse, or when consolidation of local control is needed after systemic therapy. The decision depends on factors such as the location of the lesion, stage and PET/CT response,
24-72h
Response window
Approx. $3,000
Treatment fee
Peking Union Medical College Hospital - Beijing - Grade 3A
Ruijin Hospital - Shanghai - Grade 3A
West China Hospital - Chengdu - Grade 3A
Let us coordinate the treatment journey with you.
After localization simulation, lesion-conformal/intensity-modulated radiotherapy involves creating a body position fixation device and acquiring images. Doctors delineate the target area and organs at risk, and physicists optimize the plan to cover the lesion while protecting normal tissue. Treatment is administered in fractions, often with image guidance to calibrate body position. During treatment, reactions such as skin, mucous membrane, and blood counts are assessed, and supportive treatment is adjusted as needed. The goal is to achieve the prescribed dose and local control. The above is general health information, not medical advice; specific details are subject to specialist evaluation and hospital protocols.
After localization simulation, lesion-conformal/intensity-modulated radiotherapy involves creating a body position fixation device and acquiring images. Doctors delineate the target area and organs at risk, and physicists optimize the plan to cover the lesion while protecting normal tissue. Treatment is administered in fractions, often with image guidance to calibrate body position. During treatment, reactions such as skin, mucous membrane, and blood counts are assessed, and supportive treatment is adjusted as needed. The goal is to achieve the prescribed dose and local control. The above is general health information, not medical advice; specific details are subject to specialist evaluation and hospital protocols.

Including evaluation, localization, and the entire course of irradiation, the stay in China is usually about 3–7 weeks; depending on the complexity of the plan and the fractionation regimen.

Tell us about your Non-Hodgkin Lymphoma case and we will help match you with the right hospital, specialist, and travel pathway.